Skip to content
Screener

Merit Medical Systems MMSI Q3 2026 earnings

Reported October 29, 2026 · After market close

Revenue$416.2MBeat by $5.7M
EPS$1.12Beat by $0.08
Revenue estimate$410.6M
EPS estimate$1.04
“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture. We experienced strong revenue growth trends in the U.S. and better-than-expected demand for Merit's products across both our Foundational and our Therapeutic platforms. We also delivered strong growth in both our non-GAAP operating profit and our non-GAAP earnings per share, which increased 17% and 22%, respectively, year-over-year.”
Martha G. Aronson

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$416.2M+8.4%
Gross profit$200.6M+7.6%
Operating income$58.8M+37.9%
Net income$42.3M+52.4%
EPS (diluted)$0.70+52.2%

Balance sheet

See full
Cash & equivalents$503.6M+28.3%
Total debt$822.1M+0.1%
Total equity$1.7B+14.1%
Total assets$2.9B+11.2%

Cash flow

See full
Operating cash flow$65.3M-12.9%
CapEx$12.3M-45.0%
Free cash flow$52.9M+0.7%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$5.58B+13.4%
Enterprise value$5.89B+10.3%
P/E34.8×-6.7×
P/S3.5×+0.1×

Profitability

See full
Gross margin49.4%+0.9pp
Operating margin13.5%+2.2pp
Net margin9.9%+1.9pp
FCF margin12.6%-1.4pp

Returns & leverage

See full
Return on equity9.8%+1.5pp
Debt / equity0.5×-0.1×
Current ratio4.5×+0.2×

Segments

By product

See full
Foundational Access$157.9M—
Foundational Original Equipment Manufacturer$46.3M—
Foundational Vascular Intervention$42.4M—
Therapeutic Vascular Intervention$35.8M—
Therapeutic Cardiac Therapies$27.5M—

By segment

See full
Single Reportable$416.2M—

FAQ

When did Merit Medical Systems report Q3 2026 earnings?
Merit Medical Systems (MMSI) reported Q3 2026 earnings on October 29, 2026 after market close.
What were Merit Medical Systems's Q3 2026 revenue and EPS?
Merit Medical Systems reported revenue of $416.2M and eps of $1.12 for Q3 2026.
Did Merit Medical Systems beat estimates in Q3 2026?
Revenue beat the consensus estimate of $410.6M by $5.7M. EPS beat the consensus estimate of $1.04 by $0.08.
How did Merit Medical Systems's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.4% from $384.2M a year earlier and eps grew 21.7% from $0.92.
Where can I find Merit Medical Systems's Q3 2026 SEC filings?
You can read the 8-K earnings release (0000856982-26-000051) and the 10-Q periodic report (0000856982-26-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.